MCID: PTY002
MIFTS: 35

Pityriasis Versicolor

Categories: Infectious diseases

Aliases & Classifications for Pityriasis Versicolor

MalaCards integrated aliases for Pityriasis Versicolor:

Name: Pityriasis Versicolor 12 55 15
Tinea Versicolor 44 63 73
Infection by Pityrosporum Furfur 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9060
ICD10 33 B36.0
ICD9CM 35 111.0
MeSH 44 D014010
SNOMED-CT 68 154395007 56454009
UMLS 73 C0040262

Summaries for Pityriasis Versicolor

PubMed Health : 63 About tinea versicolor: Tinea versicolor, also referred to as pityriasis versicolor, is a skin condition characterized by small patches of lighter or darker skin. It is caused by a type of fungus that is found on almost everyone’s skin. It is generally not harmful and it isn't contagious.Topical treatments, such as special creams or shampoos, are usually effective.

MalaCards based summary : Pityriasis Versicolor, also known as tinea versicolor, is related to epidermodysplasia verruciformis and dermatitis. An important gene associated with Pityriasis Versicolor is CAT (Catalase). The drugs Miconazole and Ketoconazole have been mentioned in the context of this disorder. Affiliated tissues include skin, and related phenotypes are Negative genetic interaction between MUS81-/- and MUS81+/+ and Negative genetic interaction between PTTG1-/- and PTTG1+/+

Disease Ontology : 12 A superficial mycosis that is a chronic, superficial fungal infection of the skin caused by Malassezia furfur, which is characterized by well-demarcated white, pink, fawn, or brownish lesions, often coalescing, and covered with thin furfuraceous scales.

Wikipedia : 76 Tinea versicolor is a condition characterized by a skin eruption on the trunk and proximal extremities.... more...

Related Diseases for Pityriasis Versicolor

Diseases related to Pityriasis Versicolor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 17)
# Related Disease Score Top Affiliating Genes
1 epidermodysplasia verruciformis 31.3 TMC6 TMC8
2 dermatitis 10.5
3 aging 10.3
4 erythrasma 10.2
5 seborrheic dermatitis 10.2
6 dermatitis, atopic 10.1
7 tinea cruris 10.1
8 pityriasis rotunda 10.1
9 tinea corporis 9.9
10 tinea pedis 9.9
11 candidiasis 9.9
12 tinea capitis 9.9
13 folliculitis 9.9
14 dermatophytosis 9.9
15 hansen's disease 9.9
16 chronic granulomatous disease 9.5 CAT TLR9
17 superficial mycosis 7.4 KRT31 STIM1 TLR9 TMC6 TMC8

Graphical network of the top 20 diseases related to Pityriasis Versicolor:



Diseases related to Pityriasis Versicolor

Symptoms & Phenotypes for Pityriasis Versicolor

GenomeRNAi Phenotypes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between MUS81-/- and MUS81+/+ GR00255-A-2 9.13 KRT31 TMC6 TMC8
2 Negative genetic interaction between PTTG1-/- and PTTG1+/+ GR00255-A-4 8.8 KRT31 SQLE TMC8

Drugs & Therapeutics for Pityriasis Versicolor

PubMedHealth treatment related to Pityriasis Versicolor: 63

Tinea versicolor may improve a little in cool or dry weather, but it usually doesn’t go away on its own. There are a number of effective treatments. These mainly include creams, lotions and shampoos that contain antifungal substances. They are applied to all of the affected areas of skin on the head and body. The shampoo is used too, in order to get rid of the fungus on the scalp and hair. Otherwise it might spread back to the skin again. Depending on the exact product used, it needs to be left on for anywhere from a few minutes to several hours. The products are often put on in the evening and then rinsed off in the shower the next morning.But even when treatment works, it can take up to several weeks or months for the skin patches to disappear. Only in rare cases are tablets needed.Sometimes tinea versicolor comes back again after successful treatment. If this keeps happening, doctors sometimes recommend using a special shampoo (containing an active ingredient like selenium sulfide or ketoconazole) on your skin and hair every two to four weeks. There are also oral medications (tablets) that can be taken every four weeks to prevent tinea versicolor from returning. This can greatly reduce the risk of it coming back.

Drugs for Pityriasis Versicolor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
2
Ketoconazole Approved, Investigational Phase 4 65277-42-1 47576 3823
3
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
4 Steroid Synthesis Inhibitors Phase 4
5 Cytochrome P-450 CYP3A Inhibitors Phase 4
6 Cytochrome P-450 Enzyme Inhibitors Phase 4
7 Hormone Antagonists Phase 4
8 Hormones Phase 4
9 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
10 Anti-Infective Agents Phase 4
11 Antifungal Agents Phase 4

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Ketoconazole Foam 2% for the Treatment of Versicolor Completed NCT00830388 Phase 4 Ketoconazole 2% Foam
2 Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children Terminated NCT01646580 Phase 4 ciclopirox

Search NIH Clinical Center for Pityriasis Versicolor

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: tinea versicolor

Genetic Tests for Pityriasis Versicolor

Anatomical Context for Pityriasis Versicolor

MalaCards organs/tissues related to Pityriasis Versicolor:

41
Skin

Publications for Pityriasis Versicolor

Articles related to Pityriasis Versicolor:

(show top 50) (show all 267)
# Title Authors Year
1
Malassezia species retrieved from skin with pityriasis versicolor, seborrhoeic dermatitis and skin free of lesions: a comparison of two sampling methods. ( 29505089 )
2018
2
Correction to: Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. ( 29294237 )
2018
3
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. ( 29239242 )
2018
4
Malassezia: a case of coexisting pityriasis versicolor and Malassezia folliculitis. ( 29926112 )
2018
5
Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. ( 29159502 )
2017
6
Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia-host interaction? ( 29150273 )
2017
7
Narrow-band UV-B phototherapy: an effective and reliable treatment alternative for extensive and recurrent pityriasis versicolor. ( 28984153 )
2017
8
Atrophying Pityriasis Versicolor. ( 29249261 )
2017
9
Atrophic pityriasis versicolor occurring in a patient with SjAPgren's syndrome. ( 28100575 )
2017
10
Molecular and Phenotypic Identification and Speciation of Malassezia Yeasts Isolated from Egyptian Patients with Pityriasis Versicolor. ( 28969121 )
2017
11
Correction to: El-Housiny etA al., Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. ( 29260902 )
2017
12
Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial. ( 28120351 )
2017
13
Knowledge, perception, and practice of patients about pityriasis versicolor in Kaduna, North Central Nigeria. ( 28561308 )
2017
14
The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study. ( 27329971 )
2016
15
Atrophying pityriasis versicolor as an idiosyncratic TA cell-mediated response to Malassezia: A case series. ( 27816291 )
2016
16
Clinicomycological profile of pityriasis versicolor in Assam. ( 27166032 )
2016
17
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor. ( 27532525 )
2016
18
In vitro antifungal susceptibility of Malassezia isolates from pityriasis versicolor lesions. ( 27852993 )
2016
19
Pityriasis versicolor atrophicans mit epidermaler Atrophie. ( 27373255 )
2016
20
Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial. ( 27559523 )
2016
21
Dermoscopy as an ancillary tool for the diagnosis of pityriasis versicolor. ( 26568350 )
2015
22
Pityriasis versicolor atrophicans: Is it true atrophy or pseudoatrophy? ( 26488217 )
2015
23
SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL. ( 26422149 )
2015
24
Neonatal pityriasis versicolor. ( 25742084 )
2015
25
Pityriasis versicolor. ( 25852089 )
2015
26
A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor. ( 26419668 )
2015
27
A Novel Contrast Stain for the Rapid Diagnosis of Pityriasis Versicolor: A Comparison of Chicago Sky Blue 6B Stain, Potassium Hydroxide Mount and Culture. ( 26288400 )
2015
28
Study of the Distribution of Malassezia Species in Patients with Pityriasis Versicolor in Kolar Region, Karnataka. ( 26120178 )
2015
29
Influence of systemic corticotherapy on the triggering of pityriasis versicolor. ( 24724729 )
2014
30
A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. ( 24802530 )
2014
31
Pityriasis versicolor: an update on pharmacological treatment options. ( 24991691 )
2014
32
Identification of Malassezia Species Isolated from Patients with Pityriasis Versicolor Using PCR-RFLP Method in Markazi Province, Central Iran. ( 26056657 )
2014
33
Atrophying pityriasis versicolor. ( 24733760 )
2014
34
A study of the prevalence and precipitating factors of pruritus in pityriasis versicolor. ( 24860771 )
2014
35
Can pityriasis versicolor be treated with 2% ketoconazole foam? ( 25007370 )
2014
36
Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. ( 24746716 )
2014
37
Perineal and genital pityriasis versicolor due to Malassezia globosa. ( 24814165 )
2014
38
Atypical clinical manifestation of pityriasis versicolor in a young boy. ( 24819649 )
2014
39
An analysis of the Malassezia species distribution in the skin of patients with pityriasis versicolor in Chengdu, China. ( 25177714 )
2014
40
Pityriasis versicolor: a case of resistance to treatment. ( 23432729 )
2014
41
Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial. ( 25674122 )
2014
42
Molecular identification and prevalence of malassezia species in pityriasis versicolor patients from kashan, iran. ( 25485051 )
2014
43
A case of Becker's nevus with pityriasis versicolor. ( 24438156 )
2014
44
Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA , Brazil. ( 23739695 )
2013
45
Identification and speciation of malassezia in patients clinically suspected of having pityriasis versicolor. ( 23723483 )
2013
46
Vulvar Pityriasis Versicolor in an Immunocompetent Woman. ( 24270201 )
2013
47
Identification of Malassezia Species from Pityriasis Versicolor Lesions with a New Multiplex PCR Method. ( 24190515 )
2013
48
Molecular analysis of Malassezia species isolated from Israeli patients with pityriasis versicolor. ( 23347312 )
2013
49
Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor. ( 23952012 )
2013
50
Hair loss in pityriasis versicolor lesions: a descriptive clinicopathological study. ( 22575159 )
2013

Variations for Pityriasis Versicolor

Expression for Pityriasis Versicolor

Search GEO for disease gene expression data for Pityriasis Versicolor.

Pathways for Pityriasis Versicolor

GO Terms for Pityriasis Versicolor

Cellular components related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.46 CAT KRT31 TLR9 TMC8
2 endoplasmic reticulum membrane GO:0005789 9.35 SQLE STIM1 TLR9 TMC6 TMC8
3 endoplasmic reticulum GO:0005783 9.1 CAT SQLE STIM1 TLR9 TMC6 TMC8

Biological processes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.33 STIM1 TMC6 TMC8
2 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.26 CAT TLR9
3 cholesterol metabolic process GO:0008203 8.96 CAT SQLE
4 negative regulation of NF-kappaB transcription factor activity GO:0032088 8.62 CAT TLR9

Sources for Pityriasis Versicolor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....